A detailed history of Nisa Investment Advisors, LLC transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, Nisa Investment Advisors, LLC holds 20,343 shares of JANX stock, worth $945,949. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,343
Previous 2,751 639.48%
Holding current value
$945,949
Previous $115,000 703.48%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$35.29 - $50.26 $620,821 - $884,173
17,592 Added 639.48%
20,343 $924,000
Q2 2024

Jul 19, 2024

BUY
$35.12 - $64.78 $632 - $1,166
18 Added 0.66%
2,751 $115,000
Q1 2024

May 01, 2024

BUY
$7.93 - $49.75 $182 - $1,144
23 Added 0.85%
2,733 $102,000
Q4 2023

Jan 25, 2024

BUY
$5.85 - $11.7 $15,707 - $31,414
2,685 Added 10740.0%
2,710 $29,000
Q3 2023

Nov 02, 2023

BUY
$9.56 - $14.0 $239 - $350
25 New
25 $0

Others Institutions Holding JANX

About Janux Therapeutics, Inc.


  • Ticker JANX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,663,000
  • Market Cap $1.94B
  • Description
  • Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...
More about JANX
Track This Portfolio

Track Nisa Investment Advisors, LLC Portfolio

Follow Nisa Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nisa Investment Advisors, LLC with notifications on news.